Skip to main content

Research Repository

Advanced Search

Nonparalytic botulinum molecules for the control of pain

Mangione, A.S.; Obara, I.; Maiarú, M.; Geranton, S.M.; Tassorelli, C.; Ferrari, E.; Leese, Ch; Davletov, B.; Hunt, S.P.

Nonparalytic botulinum molecules for the control of pain Thumbnail


Authors

A.S. Mangione

I. Obara

M. Maiarú

S.M. Geranton

C. Tassorelli

E. Ferrari

Ch Leese

B. Davletov

S.P. Hunt



Abstract

Local injections of botulinum toxins have been reported to be useful not only for the treatment of peripheral neuropathic pain and migraine but also to cause long-lasting muscle paralysis, a potentially serious side effect. Recently, a botulinum A-based molecule (“BiTox”) has been synthesized that retains neuronal silencing capacity without triggering muscle paralysis. In this study, we examined whether BiTox delivered peripherally was able to reduce or prevent the increased nociceptive sensitivity found in animal models of inflammatory, surgical, and neuropathic pain. Plasma extravasation and edema were also measured as well as keratinocyte proliferation. No motor deficits were seen and acute thermal and mechanical nociceptive thresholds were unimpaired by BiTox injections. We found reduced plasma extravasation and inflammatory edema as well as lower levels of keratinocyte proliferation in cutaneous tissue after local BiTox injection. However, we found no evidence that BiTox was transported to the dorsal root ganglia or dorsal horn and no deficits in formalin-elicited behaviors or capsaicin or formalin-induced c-Fos expression within the dorsal horn. In contrast, Bitox treatment strongly reduced A-nociceptor-mediated secondary mechanical hyperalgesia associated with either complete Freund’s adjuvant (CFA)-induced joint inflammation or capsaicin injection and the hypersensitivity associated with spared nerve injury. These results imply that although local release of neuromodulators from C-fibers was inhibited by BiTox injection, C-nociceptive signaling function was not impaired. Taken together with recent clinical data the results suggest that BiTox should be considered for treatment of pain conditions in which A-nociceptors are thought to play a significant role.

Citation

Mangione, A., Obara, I., Maiarú, M., Geranton, S., Tassorelli, C., Ferrari, E., …Hunt, S. (2016). Nonparalytic botulinum molecules for the control of pain. PAIN, 157(5), 1045-1055. https://doi.org/10.1097/j.pain.0000000000000478

Journal Article Type Article
Acceptance Date Dec 22, 2015
Online Publication Date May 1, 2016
Publication Date May 1, 2016
Deposit Date May 4, 2016
Publicly Available Date May 4, 2016
Journal PAIN
Print ISSN 0304-3959
Electronic ISSN 1872-6623
Publisher Lippincott, Williams & Wilkins
Peer Reviewed Peer Reviewed
Volume 157
Issue 5
Pages 1045-1055
DOI https://doi.org/10.1097/j.pain.0000000000000478
Public URL https://durham-repository.worktribe.com/output/1405646

Files

Published Journal Article (812 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/

Copyright Statement
© 2016 International Association for the Study of Pain. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.




You might also like



Downloadable Citations